(S)-N-((3S,5S,6R)-6-methyl-2-oxo-5-(phenyl-d5)-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide
Ubrogepant-d5 is a fully characterized chemical compound used as a reference standard of API Ubrogepant. The standard offered is compliant with regulatory guidelines. Ubrogepant-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
